185 related articles for article (PubMed ID: 9660462)
21. The targets of the lytic antibody response against Trypanosoma cruzi.
Krautz GM; Kissinger JC; Krettli AU
Parasitol Today; 2000 Jan; 16(1):31-4. PubMed ID: 10637586
[TBL] [Abstract][Full Text] [Related]
22. Influence of male gonadal hormones on the parasitemia and humoral response of male Calomys callosus infected with the Y strain of Trypanosoma cruzi.
do Prado JC; Levy AM; Leal MP; Bernard E; Kloetzel JK
Parasitol Res; 1999 Oct; 85(10):826-9. PubMed ID: 10494808
[TBL] [Abstract][Full Text] [Related]
23. Detection of Trypanosoma-decay accelerating factor antibodies in mice and humans infected with Trypanosoma cruzi.
Tambourgi DV; Cavinato RA; De Abreu CM; Peres BA; Kipnis TL
Am J Trop Med Hyg; 1995 Jun; 52(6):516-20. PubMed ID: 7611557
[TBL] [Abstract][Full Text] [Related]
24. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
Gazzinelli RT; Galvão LM; Cardoso JE; Cançado JR; Krettli AU; Brener Z; Gazzinelli G
J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
[TBL] [Abstract][Full Text] [Related]
25. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
[TBL] [Abstract][Full Text] [Related]
26. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
[TBL] [Abstract][Full Text] [Related]
27. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
[TBL] [Abstract][Full Text] [Related]
28. Lytic antibodies elicited by Trypanosoma cruzi infection recognize epitopes present on both bloodstream trypomastigote and epimastigote forms of parasite.
Takehara HA; Cardoso DF; da Silva AM; Mota I
Rev Inst Med Trop Sao Paulo; 1988; 30(5):351-6. PubMed ID: 2471248
[No Abstract] [Full Text] [Related]
29. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to T. cruzi cytosol acidic antigens (FIV) in Chagas' disease recognize parasite cell surface and human heart epitopes.
Gea S; Gruppi A; Basso B; Menso E; Vottero-Cima E
J Clin Lab Immunol; 1990 Apr; 31(4):183-7. PubMed ID: 1726727
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
Xu BX; Powell MR
J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
[TBL] [Abstract][Full Text] [Related]
32. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice.
de Gaspari EN; Umezawa ES; Zingales B; Stolf AM; Colli W; Abrahamsohn IA
Mem Inst Oswaldo Cruz; 1990; 85(3):261-70. PubMed ID: 2134701
[TBL] [Abstract][Full Text] [Related]
34. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies.
Cimino RO; Rumi MM; Ragone P; Lauthier J; D'Amato AA; Quiroga IR; Gil JF; Cajal SP; Acosta N; Juárez M; Krolewiecki A; Orellana V; Zacca R; Marcipar I; Diosque P; Nasser JR
Parasitology; 2011 Jul; 138(8):995-1002. PubMed ID: 21518468
[TBL] [Abstract][Full Text] [Related]
35. [Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease].
Alberti Amador E; Fachado Carvajales A; Montalvo AM; Izquierdo Pérez LA; Fonte Galindo L
Rev Cubana Med Trop; 1998; 50(1):75-81. PubMed ID: 9842273
[TBL] [Abstract][Full Text] [Related]
36. Correlation between the virulence of T. cruzi strains, complement regulatory protein expression levels, and the ability to elicit lytic antibody production.
Henrique PM; Marques T; da Silva MV; Nascentes GAN; de Oliveira CF; Rodrigues V; Gómez-Hernández C; Norris KA; Ramirez LE; Meira WSF
Exp Parasitol; 2016 Nov; 170():66-72. PubMed ID: 27614283
[TBL] [Abstract][Full Text] [Related]
37. Serum antibodies to Trypanosoma cruzi antigens in Atacameños patients from highland of northern Chile.
González J; Neira I; Gutiérrez B; Anacona D; Manque P; Silva X; Marín S; Sagua H; Vergara U
Acta Trop; 1996 Feb; 60(4):225-36. PubMed ID: 8659322
[TBL] [Abstract][Full Text] [Related]
38. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
[TBL] [Abstract][Full Text] [Related]
39. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
Milani SR; Travassos LR
Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: different surface antigens of trypomastigotes are targets of lytic antibodies.
Umezawa ES; Stolf AM; Zingales B
Acta Trop; 1993 Jun; 54(1):41-53. PubMed ID: 7690181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
